FDA pushes back deadline on NPS app; Sanofi's R&D shift incites opposition in France; MEI acquires S*BIO drug rights;

 @FierceBiotech: FDA taps data-mining tech for drug safety research. More | Follow @FierceBiotech

 @JohnCFierce: Elcelyx sheds stealth status, adds venture bucks as it seeks obesity pacts. More | Follow @JohnCFierce

 @RyanMFierce: Mount Sinai's Eric Schadt reflects on first year at $100 million genomics center. More | Follow @RyanMFierce

> The FDA has extended its deadline for a decision on NPS Pharmaceuticals' NDA for Gattex, a treatment for short bowel syndrome. The new PDUFA date is December 30, 2012. Release

> Sanofi ($SNY) isn't making many friends in France as it shifts its R&D presence more towards Cambridge, MA. Story

> MEI Pharma is acquiring S*BIO's rights to Pracinostat, an oral histone deacetylase (HDAC) inhibitor. Release

Pharma News

 @FiercePharma: "Unnerved" by "weakness in the base business," Jefferies downgrades Glaxo to "hold." Next year = better, firm says. More | Follow @FiercePharma

> NICE stiff-arms Roche melanoma drug once again. News

> Sun finally nabs Taro with $600M deal. News

> Icahn accuses Forest of hidden 'poison pill.' More

> It's official: Pfizer files its animal-health IPO. Report

Medical Device News

 @FierceMedDev: Given Imaging's rough stock slump last week was a major overreaction, at least one analyst is saying--via Bloomberg. More | Follow @FierceMedDev

 @MarkHFierce: MIT tech helped U.K. scientists discover a new class of polymers that could coat med devices and help reduce bacteria. Story | Follow @MarkHFierce

 @DamianFierce: Medtronic is looking to get a foothold in China with some M&A. More | Follow @DamianFierce

> U.K. researchers wield MIT tech to discover new class of antimicrobial polymers. Item

> FDA clears Stryker's next-gen stroke treatment device. News

Biotech IT News

> BioClinica accelerates spending to support eClinical surge. Article

> Sanofi trains social-media eye on diabetics. Story

> U.K. scientists tap into e-health research with Centers of Excellence. More

CRO News

> Theorem and Gallus team up to offer CRO, CMO services. Article

> Charles River bolsters IT spending to stand out in CRO crowd. Story

> Fuji Pharma jumps into CMO game with $53.4M plant buy. More

And Finally… Another study has concluded that a daily dose of aspirin can reduce the risk of dying from cancer. Story


Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.